Drug research: marketing before evidence, sales before safety.
作者信息
Klemperer David
出版信息
Dtsch Arztebl Int. 2010 Apr;107(16):277-8. doi: 10.3238/arztebl.2010.0277. Epub 2010 Apr 23.
Abstract
摘要
相似文献
1
Drug research: marketing before evidence, sales before safety.
Dtsch Arztebl Int. 2010 Apr;107(16):277-8. doi: 10.3238/arztebl.2010.0277. Epub 2010 Apr 23.
2
Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.
J Clin Psychopharmacol. 2012 Jun;32(3):435. doi: 10.1097/JCP.0b013e318253d737.
3
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23.
4
Comments on cost analysis of risperidone versus olanzapine.
J Clin Psychiatry. 2004 Jun;65(6):879-80; author reply 880. doi: 10.4088/jcp.v65n0622c.
5
Yes, industry influence is excessive.
Int Psychogeriatr. 2007 Dec;19(6):1004-10; discussion 1014-20. doi: 10.1017/S1041610207006217. Epub 2007 Aug 22.
6
The impact of selective publication on clinical research in pain.
Pain. 2008 Dec;140(3):401-404. doi: 10.1016/j.pain.2008.10.026. Epub 2008 Nov 11.
7
Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
BMJ. 2012 Oct 2;345:e6633. doi: 10.1136/bmj.e6633.
8
[The difficult relationship of industry and science. Money versus research].
Pflege Z. 2011 Aug;64(8):454-5.
9
Correspondence (letter to the editor): Need for advice.
Dtsch Arztebl Int. 2010 Sep;107(38):672; author reply 673-4. doi: 10.3238/arztebl.2010.0672. Epub 2010 Sep 24.
10
Practical and political problems with a global research tax.
Am J Bioeth. 2010 Jun;10(6):44-5. doi: 10.1080/15265161.2010.481347.
引用本文的文献
1
Commentary: Reconsidering Pharmaceutical Research and Development Investments.
Healthc Policy. 2023 Feb;18(3):25-30. doi: 10.12927/hcpol.2023.27037.
2
Reconsidering evidence-based management of endometriosis.
Facts Views Vis Obgyn. 2022 Sep;14(3):225-233. doi: 10.52054/FVVO.14.3.033.
3
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.
J Addict Res Ther. 2012 Nov 27;3(5):139. doi: 10.4172/2155-6105.1000139.
4
[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].
Med Klin (Munich). 2010 Dec;105(12):930-5. doi: 10.1007/s00063-010-1159-7. Epub 2011 Jan 16.
本文引用的文献
1
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23.
2
Setting the RECORD Straight.
JAMA. 2010 Mar 24;303(12):1194-5. doi: 10.1001/jama.2010.333.
3
Undisclosed changes in outcomes in randomized controlled trials: an observational study.
Ann Fam Med. 2009 Nov-Dec;7(6):542-6. doi: 10.1370/afm.1017.
4
[The German Clinical Trials Register: reasons, general and technical aspects, international integration].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Apr;52(4):463-8. doi: 10.1007/s00103-009-0833-5.
5
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.
JAMA. 2008 Apr 16;299(15):1813-7. doi: 10.1001/jama.299.15.1813.
6
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.
Am J Psychiatry. 2006 Feb;163(2):185-94. doi: 10.1176/appi.ajp.163.2.185.
7
Failing the public health--rofecoxib, Merck, and the FDA.
N Engl J Med. 2004 Oct 21;351(17):1707-9. doi: 10.1056/NEJMp048286. Epub 2004 Oct 6.
8
Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
JAMA. 2003;289(4):454-65. doi: 10.1001/jama.289.4.454.
Zotero 插件